Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
Details for Australian Patent Application No. 2003280442 (hide)
International Classifications
Event Publications
26 February 2004 Complete Application Filed
Priority application(s): 60/392,311 01.07.02 US
4 March 2004 Application Open to Public Inspection
Published as AU-B-2003280442
5 February 2009 Application Accepted
Published as AU-B-2003280442
4 June 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser